Article Details
Retrieved on: 2021-12-18 04:12:26
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Dec 17 (Reuters) - The U.S. Food and Drug Administration approved AstraZeneca and Amgen's drug, Tezspire, to treat severe asthma for those aged 12 ...
Article found on: www.marketscreener.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here